Literature DB >> 8782041

Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2.

M Piantanida1, E Buscarini, C Dellavecchia, A Minelli, A Rossi, L Buscarini, C Danesino.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is a genetically heterogeneous dominant disorder. Two disease loci have been mapped to chromosomes 9q3 and 12q. In a large pedigree, with an unusually high number of patients with liver vascular malformations, both previously mapped loci have been excluded. The loci for two other inherited vascular malformation diseases, cerebral cavernous malformations and multiple cutaneous and mucosal venous malformations, have also been excluded. Thus we conclude that at least a third, as yet unmapped, HHT locus does exist, possibly associated with high frequency of liver involvement.

Entities:  

Mesh:

Year:  1996        PMID: 8782041      PMCID: PMC1050627          DOI: 10.1136/jmg.33.6.441

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Familial occurrence of hyperdynamic circulation status due to intrahepatic fistulae in hereditary hemorrhagic telangiectasia.

Authors:  N Nikolopoulos; E Xynos; J S Vassilakis
Journal:  Hepatogastroenterology       Date:  1988-08

2.  Genetic heterogeneity in hereditary haemorrhagic telangiectasia.

Authors:  M E Porteous; A Curtis; O Williams; D Marchuk; S S Bhattacharya; J Burn
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

3.  Anastasia and the tools of justice.

Authors: 
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

4.  Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994.

Authors:  S Povey; J Armour; P Farndon; J L Haines; M Knowles; F Olopade; A Pilz; J A White; D J Kwiatkowski
Journal:  Ann Hum Genet       Date:  1994-07       Impact factor: 1.670

5.  Avoiding recomputation in linkage analysis.

Authors:  A A Schäffer; S K Gupta; K Shriram; R W Cottingham
Journal:  Hum Hered       Date:  1994 Jul-Aug       Impact factor: 0.444

6.  A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.

Authors:  D W Johnson; J N Berg; C J Gallione; K A McAllister; J P Warner; E A Helmbold; D S Markel; C E Jackson; M E Porteous; D A Marchuk
Journal:  Genome Res       Date:  1995-08       Impact factor: 9.043

7.  A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34.

Authors:  M T McDonald; K A Papenberg; S Ghosh; A A Glatfelter; B B Biesecker; E A Helmbold; D S Markel; A Zolotor; W C McKinnon; J L Vanderstoep
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype.

Authors:  K A McAllister; F Lennon; B Bowles-Biesecker; W C McKinnon; E A Helmbold; D S Markel; C E Jackson; A E Guttmacher; M A Pericak-Vance; D A Marchuk
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

9.  Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings.

Authors:  E Buscarini; L Buscarini; G Civardi; S Arruzzoli; G Bossalini; M Piantanida
Journal:  AJR Am J Roentgenol       Date:  1994-11       Impact factor: 3.959

10.  Assignment of a locus for dominantly inherited venous malformations to chromosome 9p.

Authors:  L M Boon; J B Mulliken; M Vikkula; H Watkins; J Seidman; B R Olsen; M L Warman
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

View more
  19 in total

Review 1.  Supermodels and disease: insights from the HHT mice.

Authors:  C L Shovlin
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

3.  Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients.

Authors:  A M Assis; F F Costa; V R Arruda; J M Annichino-Bizzacchi; C S Bertuzzo
Journal:  J Hum Genet       Date:  2007-01-12       Impact factor: 3.172

Review 4.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.

Authors:  G M Wallace; C L Shovlin
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

6.  The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.

Authors:  J N Berg; C J Gallione; T T Stenzel; D W Johnson; W P Allen; C E Schwartz; C E Jackson; M E Porteous; D A Marchuk
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

7.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

8.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

Review 9.  Giant spinal perimedullary fistula in hereditary haemorrhagic telangiectasia: diagnosis, endovascular treatment and review of the literature.

Authors:  F Mont'Alverne; M Musacchio; V Tolentino; F Belzile; C Riquelme; A Tournade
Journal:  Neuroradiology       Date:  2003-10-14       Impact factor: 2.804

10.  Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Authors:  N Pece; S Vera; U Cymerman; R I White; J L Wrana; M Letarte
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.